P-Selectin (Granule Membrane Protein 140) Market Share, Size, Definition, Causes, Syndrome, Pipeline Review, H1 2016

Submitted by: Submitted by

Views: 10

Words: 1170

Pages: 5

Category: Business and Industry

Date Submitted: 10/17/2016 12:27 AM

Report This Essay

P-Selectin (Granule Membrane Protein 140) Market Share,

Definition, Treatment, Causes, Pipeline Review, H1 2016 by

Radiant Insights

Summary

Global Markets Direct's, 'P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent GranuleExternal Membrane Protein or CD62P) - Pipeline Review, H1 2016', provides in depth analysis on P-Selectin

(Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P)

targeted pipeline therapeutics.

The report provides comprehensive information on the P-Selectin (Granule Membrane Protein 140 or Platelet

Activation Dependent Granule-External Membrane Protein or CD62P), targeted therapeutics, complete with

analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and

molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete

research and development history and latest news and press releases. Additionally, the report provides an

overview of key players involved in P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent

Granule-External Membrane Protein or CD62P) targeted therapeutics development and features dormant and

discontinued projects.

Browse Complete Summary Click Here @ http://www.radiantinsights.com/research/p-selectin-granulemembrane-protein-140

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and

nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's

proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor

presentations and featured press releases from company/university sites and industry-specific third party sources.

Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that

all the profiles are updated...